Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Molecular Pharmacology
|
July 27, 1999
The N-terminal domain of gamma-aminobutyric Acid(B) receptors is sufficient to specify agonist and antagonist binding
B Malitschek, C Schweizer, M Keir, et al.
The European Journal of Neuroscience
|
September 30, 1998
The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons
A Copani, G Casabona, V Bruno, et al.
Molecular Pharmacology
|
April 18, 2001
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity
F Y Carroll, A Stolle, P M Beart, et al.
The Journal of Biological Chemistry
|
August 10, 2000
The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors
A Pagano, D Ruegg, S Litschig, et al.
Molecular Psychiatry
|
December 21, 2016
Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4
C Zussy, X Gómez-Santacana, X Rovira, et al.
Molecular Pharmacology
|
February 8, 2012
Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors
F Fazio, L Lionetto, G Molinaro, et al.
British Journal of Pharmacology
|
February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overview
Stephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Molecular Pharmacology
|
July 27, 1999
The N-terminal domain of gamma-aminobutyric Acid(B) receptors is sufficient to specify agonist and antagonist binding
B Malitschek, C Schweizer, M Keir, et al.
The European Journal of Neuroscience
|
September 30, 1998
The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons
A Copani, G Casabona, V Bruno, et al.
Molecular Pharmacology
|
April 18, 2001
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity
F Y Carroll, A Stolle, P M Beart, et al.
The Journal of Biological Chemistry
|
August 10, 2000
The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors
A Pagano, D Ruegg, S Litschig, et al.
Molecular Psychiatry
|
December 21, 2016
Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4
C Zussy, X Gómez-Santacana, X Rovira, et al.
Molecular Pharmacology
|
February 8, 2012
Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors
F Fazio, L Lionetto, G Molinaro, et al.
British Journal of Pharmacology
|
February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overview
Stephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Page
of 11